Nuclear Medicine, Policlinico "Tor Vergata", Viale Oxford, 81, 00133, Rome, Italy.
Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Via Montpellier 1, 00133, Rome, Italy; University of San Raffaele, Via di Val Cannuta 247, 00166, Rome, Italy; Fondazione Umberto Veronesi (FUV), Piazza Velasca 5, 20122, Milano (Mi), Italy; UniCamillus, Saint Camillus International University of Health Sciences, Rome, Italy.
Semin Cancer Biol. 2022 Sep;84:302-309. doi: 10.1016/j.semcancer.2020.01.007. Epub 2020 Jan 23.
Here we proposed the most recent innovations in the use of Breast Specific Gamma Imaging with mTc-sestamibi for the management of breast cancer patients. To this end, we reported the recent discoveries concerning: a) the implementation of both instrumental devices and software, b) the biological mechanisms involved in the mTc-sestamibi uptake in breast cancer cells, c) the evaluation of Breast Specific Gamma Imaging with mTc-sestamibi as predictive markers of metastatic diseases. In this last case, we also reported preliminary data about the capability of Breast Specific Gamma Imaging with mTc-sestamibi to identify breast cancer lesions with high propensity to form bone metastatic lesions due to the presence of Breast Osteoblast-Like Cells.
在这里,我们提出了使用乳腺特异性伽玛成像与 mTc- sestamibi 来管理乳腺癌患者的最新创新。为此,我们报告了最近在以下方面的发现:a)仪器设备和软件的实施,b)mTc-sestamibi 在乳腺癌细胞中的摄取所涉及的生物学机制,c)作为预测转移性疾病的生物标志物的 mTc-sestamibi 乳腺特异性伽玛成像的评估。在后一种情况下,我们还报告了初步数据,表明 mTc-sestamibi 乳腺特异性伽玛成像能够识别具有高形成骨转移病灶倾向的乳腺癌病变,这是由于存在乳腺成骨细胞样细胞。